Product
DZD9008+AZD4205
Aliases
DZD9008, Inapplicable
Name
DZD9008
1 clinical trial
2 drugs
1 indication
Indication
Lung CancerDrug
DZD9008Drug
AZD4205Clinical trial
A Phase II, Multicenter Study to Assess the Safety, Tolerability and Anti-tumor Efficacy of DZD9008 in Combination With AZD4205 in Standard Treatment Failed Non-Small Cell Lung Cancer (NSCLC) Patients With EGFR MutationsStatus: Recruiting, Estimated PCD: 2025-06-01